1. Progress of Chinese Medicine Induced Ferroptosis in Nasopharyngeal Carcinoma
   鑫淼 张, 2024, Advances in Clinical Medicine CrossRef
2. The role of intratumoral microorganisms in the progression and immunotherapeutic efficacy of head and neck cancer
   Xuzhe Fang et al, 2024, Oncologie CrossRef
3. A positive feedback loop between PLD1 and NF-κB signaling promotes tumorigenesis of nasopharyngeal carcinoma
   Ya-Qing Zhou et al, 2024, Journal of Genetics and Genomics CrossRef
4. EBV-positive glycoproteins associated with nasopharyngeal carcinoma
   Chenlu Zeng et al, 2024, Pathology - Research and Practice CrossRef
5. The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma
   Shuzhan Li et al, 2024, Cancers CrossRef
6. Targeting EBV‐encoded products: Implications for drug development in EBV‐associated diseases
   Mengwen Lv et al, 2024, Reviews in Medical Virology CrossRef
7. Identification and validation of immune‐related methylated genes as diagnostic and prognostic biomarkers of nasopharyngeal carcinoma
   Zhenning Zou et al, 2024, Head & Neck CrossRef
8. Letter to the Editor, “Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma”
   Mukesh Kumar Dharmalingam Jothinathan, 2024, Oral Oncology CrossRef
9. Elucidating the Immune Microenvironment and Therapeutic Targets in Nasopharyngeal Carcinoma through Bioinformatics
   Shasha He et al, 2024, Journal of Clinical Pharmacy and Therapeutics CrossRef
10. The efficacy and safety of EGFR‐TKI in recurrent/metastatic nasopharyngeal carcinoma patients: A systematic review and meta‐analysis
    Zeqi An et al, 2024, Laryngoscope Investigative Otolaryngology CrossRef
11. Additional PD-1 inhibitor improves complete response to induction chemotherapy in locally advanced nasopharyngeal carcinoma
    Yi-Feng Yu et al, 2024, Frontiers in Immunology CrossRef